[16] While some participants in clinical studies have reported menstrual changes, these are generally attributed to the metabolic effects of weight loss rather than direct drug action on reproductive tissues, and are not classified as common adverse effects in the UK product information for GLP-1 medications
Side effects may include, but are not limited to: constipation, abdominal pain, muscle loss, nausea, vomiting, diarrhea, and hair loss
Sermorelin and ipamorelin are two of the most widely prescribed growth hormone-stimulating peptides in clinical anti-aging and regenerative medicine
Avoiding saturated fats, processed foods, and sugary foods as much as possible
States will also be able to expand access to Zepbound and orforglipron through Medicaid
Early research has explored whether GLP-1 agonists might enhance outcomes in autoimmune disease